28 related articles for article (PubMed ID: 11180294)
1. Categorization of Cytochrome P4502D6 Activity Score by Urinary Amphetamine/Methamphetamine Ratios.
Chaichana J; Khamenkhetkarn M; Sastraruji T; Monum T; O'Brien TE; Amornlertwatana Y; Jaikang C
Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557212
[TBL] [Abstract][Full Text] [Related]
2. Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.
Fricke-Galindo I; Céspedes-Garro C; Rodrigues-Soares F; Naranjo ME; Delgado Á; de Andrés F; López-López M; Peñas-Lledó E; LLerena A
Pharmacogenomics J; 2016 Apr; 16(2):113-23. PubMed ID: 26503820
[TBL] [Abstract][Full Text] [Related]
3. CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population.
He N; Yan FX; Huang SL; Wang W; Xiao ZS; Liu ZQ; Zhou HH
Eur J Clin Pharmacol; 2002 Apr; 58(1):15-8. PubMed ID: 11956668
[TBL] [Abstract][Full Text] [Related]
4. CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population.
Jurima-Romet M; Goldstein JA; LeBelle M; Aubin RA; Foster BC; Walop W; Rode A
Pharmacogenetics; 1996 Aug; 6(4):329-39. PubMed ID: 8873219
[TBL] [Abstract][Full Text] [Related]
5. A methodological investigation on the estimation of the S-mephenytoin hydroxylation phenotype using the urinary S/R ratio.
Tybring G; Bertilsson L
Pharmacogenetics; 1992 Oct; 2(5):241-3. PubMed ID: 1306124
[TBL] [Abstract][Full Text] [Related]
6. Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.
Brockmöller J; Rost KL; Gross D; Schenkel A; Roots I
Pharmacogenetics; 1995 Apr; 5(2):80-8. PubMed ID: 7663532
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population.
de Morais SM; Goldstein JA; Xie HG; Huang SL; Lu YQ; Xia H; Xiao ZS; Ile N; Zhou HH
Clin Pharmacol Ther; 1995 Oct; 58(4):404-11. PubMed ID: 7586932
[TBL] [Abstract][Full Text] [Related]
8. Phenotype analysis of cytochrome P450 2C19 in Chinese subjects with mephenytoin S/R enantiomeric ratio in urine measured by chiral GC.
Yao TW; Zeng S; Wang TW; Chen SQ
Biomed Chromatogr; 2001 Feb; 15(1):9-13. PubMed ID: 11180294
[TBL] [Abstract][Full Text] [Related]
9. [The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].
Lou YQ; Kuang TY
Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):23-8. PubMed ID: 7604218
[TBL] [Abstract][Full Text] [Related]
10. Individual and ethnic differences in CYP2C19 activity in Chinese populations.
Shu Y; Zhou HH
Acta Pharmacol Sin; 2000 Mar; 21(3):193-9. PubMed ID: 11324414
[No Abstract] [Full Text] [Related]
11. CYP2C19 genotype determines enzyme activity and inducibility of S-mephenytoin hydroxylase.
Zhou HH
Clin Chim Acta; 2001 Nov; 313(1-2):203-8. PubMed ID: 11694260
[TBL] [Abstract][Full Text] [Related]
12. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.
Bertilsson L
Clin Pharmacokinet; 1995 Sep; 29(3):192-209. PubMed ID: 8521680
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
